Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
$5.3M
Market Cap • 11/18/20242011
(13 years)
2016
(8 years ago)
NASDAQ
Listing Exchange
Cambridge
Headquarters • MassachusettsPremium
...and much more!